24/7
Buzz
Startups
VC
AI
Innovation
Opinions
Events
Promising Startups 2024
BiblioTech
Boarding Pass
Corporate
Appointments
CTalk
Tech Gateways
2025 VC survey
@Finance
Ctech Testimonials
Shopping
Projects
About
Newsletter
Contact us
RSS
Facebook
Twitter
ACCESSIBILITY
by
Homepage
Patent
Tags search
HOME
24/7
buzz
STARTUPS
VC
AI
Innovation
OPINIONS
EVENTS
SHOPPING
ABOUT
Terms Of Use
Privacy Policy
NEWSLETTER
SEARCH
CONTACT US
ACCESSIBILITY
24/7
Headlines
12:54
From near-death in Gaza to a $100 million exit: Itamar Ben Hemo’s extraordinary journey
11:21
Mixpanel is here to help gaming companies democratize their data
09:10
Here’s how gaming brands can reach wider audiences: “Never make assumptions!”
09:01
Israel’s gaming sector is 2% of its GDP - so why is the government ignoring it?
More stories
Buzz
Most popular
Daily
Weekly
1
From near-death in Gaza to a $100 million exit: Itamar Ben Hemo’s extraordinary journey
2
TechAir flights from Israel to New York take off January 21
3
Defense tech is booming—but who will actually win?
4
Windward acquired for $270M by FTV Capital, doubling its IPO valuation
5
$41B in exits: Why Israeli cyber startups are a global powerhouse
More news
Patent
2 stories about Patent
Teva’s Stock Drops After Approval of Copaxone Competitors
08.10.17
|
Lilach Baumer
A day after Mylan announced FDA approval for its generic versions of Copaxone, drug companies Synthon and Alvogen announce European approval for their 40 mg/ml generic versions of Teva's blockbuster drug
Your First Investor Meeting, a Survival Guide
27.09.17
|
Zachi Zach
Your first meeting with a potential investor is critical because you probably won’t get another chance. Do your homework
Previous Articles
Please ensure Javascript is enabled for purposes of
website accessibility